P. Grecka

Comparative in vitro interactions of ceftazidime, meropenem, and imipenem with amikacin on multiresistant Pseudomonas aeruginosa

Evangelos J. Giamarellos‐Bourboulis, P. Grecka, Helen Giamarellou · Diagnostic Microbiology and Infectious Disease · 1997 · 177 citations

Multiresistant Pseudomonas Aeruginosa, Antimicrobial Susceptibility, Antibiotics +9

Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient?

Evangelos J. Giamarellos‐Bourboulis, Anna Mega, P. Grecka et al. · Intensive Care Medicine · 2002 · 152 citations

Inflammation, Translational Medicine, Acute Care +6

Assessment of Procalcitonin as a Diagnostic Marker of Underlying Infection in Patients with Febrile Neutropenia

Evangelos J. Giamarellos‐Bourboulis, P. Grecka, Konstantinos Anargyrou et al. · Clinical Infectious Diseases · 2001 · 103 citations · Full text

Severe Sepsis, Diagnosis, Pathology +17

Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia: experience from a multicentre study

Helen Giamarellou, Evangelos J. Giamarellos‐Bourboulis, Panagiotis Repoussis et al. · Clinical Microbiology and Infection · 2004 · 96 citations · Full text

Diagnostic Criterion, Potential Use, Diagnosis +3

Should procalcitonin be introduced in the diagnostic criteria for the systemic inflammatory response syndrome and sepsis?

Evangelos J. Giamarellos‐Bourboulis, P. Grecka, Dionyssios Voros et al. · Journal of Critical Care · 2004 · 65 citations

Inflammation, Translational Medicine, Chronic Inflammation +6